[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565880":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":33,"collaborators":35,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"IRCCS Policlinico S. Donato","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"BrS Affected",null,"The Study population will be composed by patients affected by the Brugada Syndrome, including both the ones already under teatment and subjects with new diagnosis.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Giuseppe Ciconte MD, PhD","CONTACT","+390252774260","Giuseppe.Ciconte@grupposandonato.it",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":10},"Irccs Policlinico San Donato","RECRUITING","San Donato Milanese","Milan","20097","Italy","IT",{"type":28,"coordinates":29},"Point",[30,31],9.26838,45.41047,{"lat":31,"lon":30},{"type":34,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[36,38],{"name":37,"class":6},"Azienda Ospedaliero Universitaria di Sassari",{"name":39,"class":40},"The National Research Council, Italy","OTHER_GOV","100565880","genlab-unveiling-the-genetic-landscape-of-brugada-syndrome-novel-biomarker-discovery-for-precise-diagnosis-100565880",false,"NCT06647927","GenLab: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise Diagnosis","Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise Diagnosis","GenLaB","Inclusion Criteria:\n\n* Age \\> 18 years\n* Patients affected by Brugada Syndrome\n* Patients who signs the Informed Consent\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":52,"type":53},350,"ESTIMATED","OBSERVATIONAL","This research makes several significant contributions to the field of BrS. It employs advanced genetic sequencing techniques to develop a genetic signature to improve the accuracy and efficiency of BrS diagnosis. The identification of specific biomolecular profiles and genetic signatures enhances our understanding of the syndrome's molecular mechanisms, facilitating targeted therapies and refined risk stratification. These advancements optimize patient care by enabling personalized treatment plans and risk assessment. Overall, this research adds value by advancing diagnostic methods, providing molecular insights, optimizing patient care, and positively impacting public health outcomes in BrS.",[57],"Brugada Syndrome (BrS)","2025-05-13",{"date":60,"type":61},"2025-05-14","ACTUAL",{"date":63,"type":61},"2024-12-02",{"date":65,"type":53},"2026-09",{"name":5,"class":6},1]